Cerebyx

Active Ingredient(s): Fosphenytoin
FDA Approved: * August 5, 1996
Pharm Company: * PARKE DAVIS
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cerebyx Overview

Fosphenytoin (fosphenytoin sodium, trade names Cerebyx, Parke-Davis; Prodilantin, Pfizer Holding France[1]) is a water-soluble phenytoin prodrug that is administered intravenously to deliver phenytoin, potentially more safely than intravenous phenytoin. It is most commonly used in the acute treatment of convulsive status epilepticus. Fosphenytoin was developed in 1996.[2] On 18 November 2004, Sicor (a subsidiary of Teva) received a tentative approval letter fro...

Read more Cerebyx Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fosphenytoin

Recent Cerebyx Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fosphenytoin
  • Injection: 50mg, 50mg/ml, 75mg/ml, eq 50mg phenytoin na/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cerebyx: (3 results)

Sorted by National Drug Code
  • 0069-5471 Cerebyx 50 mg/ml Intramuscular; Intravenous Injection, Solution by Pfizer Laboratories
  • 0069-5474 Cerebyx 50 mg/ml Intramuscular; Intravenous Injection, Solution by Pfizer Laboratories
  • 0069-6001 Cerebyx 50 mg/ml Intramuscular; Intravenous Injection, Solution by Pfizer Laboratories

Other drugs which contain Fosphenytoin or a similar ingredient: (1 result)

Related Cerebyx Topics:

Cerebyx
I need info on the drug cerebyx...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA